ASTRAZEN - Astrazeneca Pharma India

Astrazeneca Pharma India

ASTRAZEN · Pharma > Pharmaceuticals & Drugs · Chairman: Narayan K Seshadri · MD: Gagandeep Singh Bedi · Listing date: July 29, 1998 · Employees: 1283 · Bangalore · http://www.astrazeneca.in

Stock Price vs Company Growth

2.7%

2.4%

7.5%

3.6%

6.5%

18.2%

19.5%

10y

22.8%

all

15.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 8,827 2.7%

8,027

9,449

Company Overview

Sales

2,177 Cr

Growth: 29.5%

Profit after Tax

199 Cr

Growth: 0.1%

Mid Cap

22,067 Cr

P/E: 109.8x

Industry P/E: 29.7x

Fundamentals

Sales (Cr)	₹ 2,177
Growth	29.5%
EBITDA	13.2%
P/S	10.1x
Dividend	0.3%
P/E	109.8x
Book Value	₹ 365
PEG Ratio	3.7x
ROE	23.5%
P/B	24.2x

Shareholding Pattern

Institutions

Promoters

Astrazeneca Pharmaceuticals Ab

75.0 %

Others

Tejas Bhalchandra Trivedi

2.67 %

Shivani T. Trivedi

1.98 %

Minaxi Bhalchandra Trivedi

1.84 %

Iepf

0.46 %

Increase Decrease No change

Company Profile Detailed

The Company is engaged in the business of manufacture, distribution and marketing of life-changing medicines in crucial areas of healthcare including oncology, cardiovascular, diabetes, renal, metabolic and respiratory.Core Therapy AreasCardiovascularOncologyRespiratoryMilestones and achievements1979: Astra IDL formation.1982: Astra factory foundation.1992: Launch of Cerviprime, Plendil, Ramace, Rhinocort and Imdur.

Belongs to (27 Indices) view more

Investors (43)

astra.ph...

all.body...

mansfiel...

Followers (3)

nitin2

keerthi

deepak